These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 25759125)

  • 1. Reactivation of persistent Epstein-Barr virus (EBV) causes secretion of thyrotropin receptor antibodies (TRAbs) in EBV-infected B lymphocytes with TRAbs on their surface.
    Nagata K; Nakayama Y; Higaki K; Ochi M; Kanai K; Matsushita M; Kuwamoto S; Kato M; Murakami I; Iwasaki T; Nanba E; Kimura H; Hayashi K
    Autoimmunity; 2015; 48(5):328-35. PubMed ID: 25759125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subclinical Epstein-Barr Virus Primary Infection and Lytic Reactivation Induce Thyrotropin Receptor Autoantibodies.
    Tamoto N; Nagata K; Hara S; Nakayama Y; Kuwamoto S; Matsushita M; Kato M; Hayashi K
    Viral Immunol; 2019 Nov; 32(9):362-369. PubMed ID: 31580214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Presence of Epstein-Barr virus-infected B lymphocytes with thyrotropin receptor antibodies on their surface in Graves' disease patients and in healthy individuals.
    Nagata K; Higaki K; Nakayama Y; Miyauchi H; Kiritani Y; Kanai K; Matsushita M; Iwasaki T; Sugihara H; Kuwamoto S; Kato M; Murakami I; Nanba E; Kimura H; Hayashi K
    Autoimmunity; 2014 May; 47(3):193-200. PubMed ID: 24467196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epstein-Barr Virus Lytic Reactivation Activates B Cells Polyclonally and Induces Activation-Induced Cytidine Deaminase Expression: A Mechanism Underlying Autoimmunity and Its Contribution to Graves' Disease.
    Nagata K; Kumata K; Nakayama Y; Satoh Y; Sugihara H; Hara S; Matsushita M; Kuwamoto S; Kato M; Murakami I; Hayashi K
    Viral Immunol; 2017 Apr; 30(3):240-249. PubMed ID: 28333576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estradiol Affects Epstein-Barr Virus Reactivation-Induced Thyrotropin Receptor Antibody and Immunoglobulin Production in Graves' Disease Patients and Healthy Controls.
    Hara S; Nagata K; Kumata K; Matsushita M; Kuwamoto S; Kato M; Hayashi K
    Viral Immunol; 2018 Sep; 31(7):486-491. PubMed ID: 30133352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epstein-Barr Virus Lytic Reactivation Induces IgG4 Production by Host B Lymphocytes in Graves' Disease Patients and Controls: A Subset of Graves' Disease Is an IgG4-Related Disease-Like Condition.
    Nagata K; Hara S; Nakayama Y; Higaki K; Sugihara H; Kuwamoto S; Matsushita M; Kato M; Tanio S; Ishiguro K; Hayashi K
    Viral Immunol; 2018 Oct; 31(8):540-547. PubMed ID: 30222515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of Epstein-Barr virus reactivation in patients with Graves' disease.
    Nagata K; Fukata S; Kanai K; Satoh Y; Segawa T; Kuwamoto S; Sugihara H; Kato M; Murakami I; Hayashi K; Sairenji T
    Viral Immunol; 2011 Apr; 24(2):143-9. PubMed ID: 21449724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epstein-Barr virus reactivation in peripheral B lymphocytes induces IgM-type thyrotropin receptor autoantibody production in patients with Graves' disease.
    Nagata K; Hayashi K; Kumata K; Satoh Y; Osaki M; Nakayama Y; Kuwamoto S; Ichihara Y; Okura T; Matsuzawa K; Miake J; Fukata S; Imamura T
    Endocr J; 2023 Jun; 70(6):619-627. PubMed ID: 36908137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thyrotropin Receptor Antibody (TRAb)-IgM Levels Are Markedly Higher Than TRAb-IgG Levels in Graves' Disease Patients and Controls, and TRAb-IgM Production Is Related to Epstein-Barr Virus Reactivation.
    Kumata K; Nagata K; Matsushita M; Kuwamoto S; Kato M; Murakami I; Fukata S; Hayashi K
    Viral Immunol; 2016 Oct; 29(8):459-463. PubMed ID: 27529807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [An investigation on the percentages of TRAb-producing cells in Graves disease].
    Jia W; An Z; Chen D; Wei S
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2003 Jan; 34(1):100-3. PubMed ID: 15600195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterogeneity of Graves' immunoglobulin G: comparison of thyrotropin receptor antibodies in serum and in culture supernatants of lymphocytes transformed by Epstein-Barr virus infection.
    Yokoyama N; Izumi M; Katamine S; Nagataki S
    J Clin Endocrinol Metab; 1987 Feb; 64(2):215-8. PubMed ID: 2878934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epstein-Barr Virus Reactivation-Induced Immunoglobulin Production: Significance on Autoimmunity.
    Nagata K; Hayashi K
    Microorganisms; 2020 Nov; 8(12):. PubMed ID: 33260824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High Level Estradiol Induces EBV Reactivation and EBV gp350/220(+)CD138(+) Double-positive B Cell Population in Graves' Disease Patients and Healthy Controls.
    Hara S; Nagata K; Nakayama Y; Higaki K; Matsushita M; Kuwamoto S; Kato M; Hayashi K
    Yonago Acta Med; 2019 Jun; 62(2):240-243. PubMed ID: 31341401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Persistence of thyrotropin (TSH) receptor antibodies in children and adolescents with Graves' disease treated using antithyroid medication.
    Smith J; Brown RS
    Thyroid; 2007 Nov; 17(11):1103-7. PubMed ID: 17822376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low frequency of IL-10-producing B cells and high density of ILC2s contribute to the pathological process in Graves' disease, which may be related to elevated-TRAb levels.
    Ji X; Wan J; Chen R; Wang H; Huang L; Wang S; Su Z; Xu H
    Autoimmunity; 2020 Mar; 53(2):78-85. PubMed ID: 31809586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stimulating and blocking thyroid-stimulating hormone (TSH) receptor autoantibodies from patients with Graves' disease and autoimmune hypothyroidism have very similar concentration, TSH receptor affinity, and binding sites.
    Morgenthaler NG; Ho SC; Minich WB
    J Clin Endocrinol Metab; 2007 Mar; 92(3):1058-65. PubMed ID: 17179194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human immunoglobulin G autoantibodies to the thyrotropin receptor from Epstein-Barr virus-transformed B lymphocytes: characterization by immunoprecipitation with recombinant antigen and biological activity.
    Morgenthaler NG; Kim MR; Tremble J; Huang GC; Richter W; Gupta M; Scherbaum WA; McGregor AM; Banga JP
    J Clin Endocrinol Metab; 1996 Sep; 81(9):3155-61. PubMed ID: 8784060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The latest progress in the pathogenesis and diagnosis of Graves' disease].
    Kimura T; Okamoto Y
    Nihon Rinsho; 2012 Nov; 70(11):1908-12. PubMed ID: 23214060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinct pattern of peripheral lymphocyte subsets in Graves' disease with persistency of anti-TSHR autoantibodies.
    Teniente-Serra A; Soldevila B; Quirant-Sánchez B; Fernández MA; Ester Condins A; Puig-Domingo M; Pujol-Borrell R; Martínez-Cáceres EM
    Autoimmunity; 2019; 52(5-6):220-227. PubMed ID: 31366254
    [No Abstract]   [Full Text] [Related]  

  • 20. Correlation between serum anti-TSH receptor autoantibodies (TRAbs) and the clinical feature of Graves' orbitopathy.
    Nicolì F; Lanzolla G; Mantuano M; Ionni I; Mazzi B; Leo M; Sframeli A; Posarelli C; Maglionico MN; Figus M; Nardi M; Marcocci C; Marinò M
    J Endocrinol Invest; 2021 Mar; 44(3):581-585. PubMed ID: 32648002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.